USD 0.86
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -11.85 Million USD | -18.6% |
2022 | -9.99 Million USD | -0.52% |
2021 | -9.94 Million USD | 27.07% |
2020 | -13.64 Million USD | -101.15% |
2019 | -6.78 Million USD | 0.67% |
2018 | -6.82 Million USD | -34.96% |
2017 | -5.05 Million USD | -10488.02% |
2016 | -47.77 Thousand USD | 24.0% |
2015 | -62.86 Thousand USD | -73.44% |
2014 | -36.24 Thousand USD | -18.62% |
2013 | -30.55 Thousand USD | -118.87% |
2012 | -13.96 Thousand USD | 49.43% |
2011 | -27.6 Thousand USD | -356.72% |
2010 | -6044.00 USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -2.85 Million USD | 14.64% |
2024 Q3 | -2.76 Million USD | 3.07% |
2024 Q1 | -3.34 Million USD | -6.69% |
2023 Q2 | -3.52 Million USD | -103.31% |
2023 FY | -11.85 Million USD | -18.6% |
2023 Q4 | -3.13 Million USD | 9.62% |
2023 Q1 | -1.73 Million USD | -26.08% |
2023 Q3 | -3.46 Million USD | 1.53% |
2022 Q3 | -2.75 Million USD | 9.76% |
2022 FY | -9.99 Million USD | -0.52% |
2022 Q4 | -1.37 Million USD | 50.2% |
2022 Q2 | -3.05 Million USD | -8.93% |
2022 Q1 | -2.8 Million USD | -6.22% |
2021 Q4 | -2.64 Million USD | 10.45% |
2021 FY | -9.94 Million USD | 27.07% |
2021 Q1 | -1.95 Million USD | -245.96% |
2021 Q2 | -2.39 Million USD | -22.17% |
2021 Q3 | -2.95 Million USD | -23.3% |
2020 Q2 | -1.34 Million USD | 70.98% |
2020 Q1 | -4.63 Million USD | -242.6% |
2020 Q3 | -7.09 Million USD | -426.96% |
2020 FY | -13.64 Million USD | -101.15% |
2020 Q4 | -566.39 Thousand USD | 92.01% |
2019 Q1 | -1.35 Million USD | 46.21% |
2019 Q4 | -1.35 Million USD | 27.35% |
2019 Q3 | -1.86 Million USD | 15.78% |
2019 Q2 | -2.21 Million USD | -63.5% |
2019 FY | -6.78 Million USD | 0.67% |
2018 Q2 | -1.35 Million USD | 16.52% |
2018 Q4 | -2.51 Million USD | -99.46% |
2018 FY | -6.82 Million USD | -34.96% |
2018 Q3 | -1.26 Million USD | 7.06% |
2018 Q1 | -1.62 Million USD | -15.34% |
2017 FY | -5.05 Million USD | -10488.02% |
2017 Q4 | -1.4 Million USD | -8.87% |
2017 Q3 | -1.29 Million USD | -77.41% |
2017 Q2 | -729.57 Thousand USD | -173.9% |
2017 Q1 | -266.37 Thousand USD | -4677.08% |
2016 Q1 | -19.06 Thousand USD | -89.44% |
2016 Q2 | -8959.00 USD | 53.02% |
2016 Q4 | -5576.00 USD | 77.42% |
2016 Q3 | -24.69 Thousand USD | -175.69% |
2016 FY | -47.77 Thousand USD | 24.0% |
2015 FY | -62.86 Thousand USD | -73.44% |
2015 Q4 | -10.06 Thousand USD | 54.55% |
2015 Q3 | -22.14 Thousand USD | -91.19% |
2015 Q2 | -11.58 Thousand USD | -17.27% |
2015 Q1 | -9877.00 USD | -61.39% |
2014 Q3 | -16.01 Thousand USD | -278.88% |
2014 Q2 | -4228.00 USD | -41.26% |
2014 Q1 | -2993.00 USD | 41.67% |
2014 FY | -36.24 Thousand USD | -18.62% |
2014 Q4 | -6120.00 USD | 61.8% |
2013 Q2 | -3308.00 USD | -132.14% |
2013 Q4 | -5131.00 USD | 73.17% |
2013 Q3 | -19.12 Thousand USD | -478.05% |
2013 FY | -30.55 Thousand USD | -118.87% |
2013 Q1 | -1425.00 USD | 70.19% |
2012 Q1 | -15.51 Thousand USD | -271.33% |
2012 Q3 | -2351.00 USD | 57.82% |
2012 Q4 | -4780.00 USD | -103.32% |
2012 FY | -13.96 Thousand USD | 49.43% |
2012 Q2 | -5574.00 USD | 64.07% |
2011 Q3 | -1220.00 USD | 81.77% |
2011 Q4 | -4178.00 USD | -242.46% |
2011 Q1 | -547.00 USD | 89.48% |
2011 Q2 | -6692.00 USD | -1123.4% |
2011 FY | -27.6 Thousand USD | -356.72% |
2010 Q3 | -2779.00 USD | 0.0% |
2010 FY | -6044.00 USD | 0.0% |
2010 Q4 | -5198.00 USD | -87.05% |
Name | Net Income | Net Income Difference |
---|---|---|
Acutus Medical, Inc. | -81.66 Million USD | 85.478% |
Cerus Corporation | -37.48 Million USD | 68.365% |
OrthoPediatrics Corp. | -20.97 Million USD | 43.456% |
PetVivo Holdings, Inc. | -10.95 Million USD | -8.254% |
Talis Biomedical Corporation | -62 Million USD | 80.874% |
Vivos Therapeutics, Inc. | -13.58 Million USD | 12.689% |
Inogen, Inc. | -102.44 Million USD | 88.424% |
Spectral AI, Inc. | -20.85 Million USD | 43.131% |
Nano-X Imaging Ltd. | -60.77 Million USD | 80.487% |
CVRx, Inc. | -41.19 Million USD | 71.214% |
DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1952.478% |
Helius Medical Technologies, Inc. | -8.85 Million USD | -34.006% |
Orthofix Medical Inc. | -151.39 Million USD | 92.167% |
Venus Concept Inc. | -37.25 Million USD | 68.162% |
Accelerate Diagnostics, Inc. | -61.61 Million USD | 80.753% |
Bioventus Inc. | -156.23 Million USD | 92.409% |
BrainsWay Ltd. | -4.19 Million USD | -182.571% |
Envoy Medical, Inc. | -29.9 Million USD | 60.347% |
electroCore, Inc. | -18.83 Million USD | 37.031% |
IceCure Medical Ltd | -14.65 Million USD | 19.059% |
Lucid Diagnostics Inc. | -52.66 Million USD | 77.482% |
Monogram Orthopaedics, Inc. | -13.74 Million USD | 13.719% |
MaxCyte, Inc. | -37.92 Million USD | 68.727% |
Nexalin Technology, Inc. | -4.64 Million USD | -155.114% |
PAVmed Inc | -64.17 Million USD | 81.52% |
Rapid Micro Biosystems, Inc. | -52.46 Million USD | 77.396% |
RxSight, Inc. | -48.6 Million USD | 75.602% |
Sight Sciences, Inc. | -55.54 Million USD | 78.65% |
SI-BONE, Inc. | -43.33 Million USD | 72.634% |
TELA Bio, Inc. | -46.66 Million USD | 74.585% |
TriSalus Life Sciences, Inc. | -59.03 Million USD | 79.912% |
Treace Medical Concepts, Inc. | -49.52 Million USD | 76.054% |
LivaNova PLC | 17.54 Million USD | 167.591% |
908 Devices Inc. | -36.39 Million USD | 67.418% |
Alphatec Holdings, Inc. | -186.63 Million USD | 93.646% |
Nemaura Medical Inc. | -14.14 Million USD | 16.15% |
NeuroPace, Inc. | -32.95 Million USD | 64.014% |
LENSAR, Inc. | -14.38 Million USD | 17.545% |
Apyx Medical Corporation | -18.71 Million USD | 36.624% |
Cutera, Inc. | -162.83 Million USD | 92.717% |
STRATA Skin Sciences, Inc. | -10.83 Million USD | -9.506% |
BioSig Technologies, Inc. | -29.04 Million USD | 59.163% |
Anika Therapeutics, Inc. | -82.66 Million USD | 85.654% |
ClearPoint Neuro, Inc. | -22.08 Million USD | 46.31% |
Integra LifeSciences Holdings Corporation | 67.74 Million USD | 117.507% |
Axonics, Inc. | -6.08 Million USD | -94.801% |
Outset Medical, Inc. | -172.79 Million USD | 93.137% |
IRIDEX Corporation | -9.57 Million USD | -23.924% |
PROCEPT BioRobotics Corporation | -105.89 Million USD | 88.801% |
IRadimed Corporation | 17.19 Million USD | 168.98% |
Tivic Health Systems, Inc. | -8.24 Million USD | -43.856% |
INVO Bioscience, Inc. | -8.03 Million USD | -47.605% |
Telesis Bio, Inc. | -47.72 Million USD | 75.15% |
Viemed Healthcare, Inc. | 10.24 Million USD | 215.781% |
Varex Imaging Corporation | -47.7 Million USD | 75.137% |
Quipt Home Medical Corp. | -2.78 Million USD | -325.987% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -5.081% |
Pulmonx Corporation | -60.84 Million USD | 80.508% |
Dynatronics Corporation | -2.69 Million USD | -339.612% |
Modular Medical, Inc. | -17.47 Million USD | 32.115% |
ReShape Lifesciences Inc. | -11.38 Million USD | -4.149% |
Semler Scientific, Inc. | 20.58 Million USD | 157.618% |
InMode Ltd. | 197.91 Million USD | 105.992% |
Bruker Corporation | 427.2 Million USD | 102.776% |
Cytosorbents Corporation | -28.5 Million USD | 58.399% |
DexCom, Inc. | 541.5 Million USD | 102.19% |
Align Technology, Inc. | 445.05 Million USD | 102.665% |
Viveve Medical, Inc. | -22.02 Million USD | 46.159% |
ZimVie Inc. | -393.28 Million USD | 96.984% |
Movano Inc. | -29.28 Million USD | 59.5% |
Cytek Biosciences, Inc. | -12.14 Million USD | 2.375% |
Nexalin Technology, Inc. | -4.64 Million USD | -155.114% |
DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1952.478% |
Tandem Diabetes Care, Inc. | -222.61 Million USD | 94.673% |
Profound Medical Corp. | -28.56 Million USD | 58.488% |
Insulet Corporation | 206.3 Million USD | 105.749% |
enVVeno Medical Corporation | -23.51 Million USD | 49.568% |
Surmodics, Inc. | -11.54 Million USD | -2.751% |
iCAD, Inc. | -4.84 Million USD | -144.677% |
Nuwellis, Inc. | -20.2 Million USD | 41.316% |
Biotricity, Inc. | -14.09 Million USD | 15.856% |
iRhythm Technologies, Inc. | -123.4 Million USD | 90.39% |
Aethlon Medical, Inc. | -12.2 Million USD | 2.856% |
InspireMD, Inc. | -19.91 Million USD | 40.452% |
PAVmed Inc. | -64.17 Million USD | 81.52% |
BIOLASE, Inc. | -20.63 Million USD | 42.519% |
Beyond Air, Inc. | -60.24 Million USD | 80.314% |
FONAR Corporation | 10.56 Million USD | 212.227% |
AxoGen, Inc. | -21.71 Million USD | 45.388% |
Vivani Medical, Inc. | -25.65 Million USD | 53.768% |
Tactile Systems Technology, Inc. | 28.51 Million USD | 141.59% |
Inari Medical, Inc. | -1.63 Million USD | -624.908% |
UFP Technologies, Inc. | 44.92 Million USD | 126.399% |
QT Imaging Holdings, Inc. | -5.13 Million USD | -131.074% |
Heart Test Laboratories, Inc. | -6.6 Million USD | -79.548% |
Tenon Medical, Inc. | -15.58 Million USD | 23.885% |
Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 23.12% |
Co-Diagnostics, Inc. | -35.33 Million USD | 66.435% |
AdaptHealth Corp. | -678.89 Million USD | 98.253% |
Sintx Technologies, Inc. | -8.25 Million USD | -43.595% |
NanoVibronix, Inc. | -3.71 Million USD | -219.577% |
Quanterix Corporation | -32.33 Million USD | 63.322% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -5.081% |
Sensus Healthcare, Inc. | 485 Thousand USD | 2545.256% |
Pacific Biosciences of California, Inc. | -306.73 Million USD | 96.134% |
TransMedics Group, Inc. | -25.02 Million USD | 52.615% |
ReWalk Robotics Ltd. | -22.13 Million USD | 46.417% |
NeuroMetrix, Inc. | -6.52 Million USD | -81.63% |
Hyperfine, Inc. | -44.23 Million USD | 73.192% |
Establishment Labs Holdings Inc. | -78.5 Million USD | 84.893% |
Biomerica, Inc. | -5.97 Million USD | -98.386% |
Bone Biologics Corporation | -8.94 Million USD | -32.527% |
AVITA Medical, Inc. | -39.16 Million USD | 69.722% |
Bluejay Diagnostics, Inc. | -9.95 Million USD | -19.144% |
Silk Road Medical, Inc | -55.74 Million USD | 78.725% |